
Global Probiotics Dietary Supplements Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
-
3712
-
Upcoming
-
NA
-
PDF
-
find_in_page Our Research Methodology is based on the following main points:
- Data Collections and Interpretation
- Analysis
- Data Validation
- Final Projections and Conclusion
- notifications
- Request Covid Impact
- Table of Content
- List of Companies
- Inquiry Before Buying
- Request for Customization
-
-
MarketResearch.biz delivers in-depth insights on the global probiotics dietary supplements market in its upcoming report titled, “Global Probiotics Dietary Supplements Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global probiotics dietary supplements market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global probiotics dietary supplements market report has been segmented on the basis of application, and region.
Probiotics are defined as live microbial food ingredients that provide several benefits to human health. Probiotics dietary supplements are living microorganisms, that when consumed, benefit health by improving the balance of bacteria in intestines. The normal human digestive tract contains about 400 types of probiotic bacteria that reduce growth of harmful bacteria and promotes a healthy digestive system.
Rising health awareness among individuals, coupled with various health benefits offered by probiotics dietary supplements are major factors driving growth of the global probiotics dietary supplements market. Increasing prevalence of diseases such as obesity, diabetes, blood pressure, owing to hectic lifestyle and improper diet, use of these supplements to improve immune system, and to treat various gastrointestinal diseases, breast cancer, dental caries are other factors expected to contribute growth in the global probiotics dietary supplements market over the forecast period.
Increasing adoption of probiotics dietary supplements for preparation of specialty nutrients, in infant formulae to avoid stomach related diseases, better growth, and development of infants, and increasing use in animal feed industry are other important factors expected to support growth of this market.
However, high competition amongst players and various side effects caused due to high consumption of probiotics dietary supplements such as bloating, vomiting, diarrhea, and other gastrointestinal problems are major factors restraining growth of the global probiotics dietary supplements market. Easy availability of other supplements in market is another factor expected to hamper growth of this market over the forecast period.
The market in Europe is expected to be dominate the global probiotics dietary supplements market and account for highest share in terms of revenue, owing to presence of various domestic and international market players and increasing health concerns among individuals in the countries in the region. The market in North America is expected to account for second-highest revenue share, owing to increasing prevalence of chronic diseases in the countries in the region. The market in North America is followed by Asia Pacific, Latin America, and Middle East & Africa.
Global probiotics dietary supplements market segmentation:
Segmentation by application:
- Food supplement
- Nutritional supplements
- Specialty nutrients
- Infant formula
Segmentation by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region - North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$ -
- Bayer AG
- Hansen A/S
- The Dow Chemical Company
- Lallemand Inc.
- Probi AB
- Attune Foods, LLC
- Bifodan A/S
- Biocare Copenhagen A/S
- Deerland Enzymes, Inc.
- Vertical Pharmaceuticals Inc.
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!